Cells for Research Program

Many pharmaceutical/biotechnology companies and academic laboratories have difficulty obtaining a consistent supply of mature human hepatocytes for drug metabolism testing. As researchers at Vesta process cells for research and clinical trial programs, a significant number of surplus mature hepatocytes are collected. By supplying these excess human hepatocytes for a processing fee to other companies for use in testing of the drugs they are developing, Vesta helps to insure that the gift of life is extended to as many potentially life-saving therapies as possible.